Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes

► The secreted Ro52 autoantibody proteome was determined by de novo protein sequencing. ► The proteome is restricted to two public clonotypes shared across different diseases. ► V region peptides were used in a mass spectrometric autoantibody detection platform